Hep B & C Task Force Meeting Highlights | Staten Island | 5-2-13
May 2, 2013
Letter from NYC DOHMH stating the Incorporation of TB & STI services from DOHMH into HHC’s Stapleton Family Health Center
Related Articles
-
NYS Hep C Telemedicine Workgroup Meeting Notes | 7-16-20
Meeting focused on efforts to support HCV treatment in OTPs via telemedicine and the need for increased reimbursement rates.
-
Hep C Task Force Meeting Highlights | Harlem – 7-12-17
Presentations include the Statewide Hep C Elimination Plan, Accomplishments and Next Steps for Project INSPIRE, and NYC Policy and Advocacy Updates.
-
Research Committee Meeting Highlights | 3-24-21
Hep Free NYC Research Committee Meeting Highlights 03-24-2021 (3 – 4:30 PM EST) via Zoom Hep Free NYC Research Committee Webpage and community research board for recruiting for studies or jobs. Please share any suggestions and share with those interested in posting/utilizing.
-
2-18-15 Queens Hep B & C Task Force Meeting Notes
25 professionals convened to learn about City Council funded Hep programs and update of the NYC HEP Patient Navigator Network and other Hep B & C services available in Queens.
-
9-18-13 Hep B Coalition Meeting Highlights
View the full meeting highlights: Click Here Supporting slides and documents from the meeting: Universal Hep B Birth Dose in NYC (pdf slides) Julie Lazaroff, MPH – Bureau of Immunization, NYC DOHMH (jlazarof@health.nyc.gov) NYC DOHMH Hep B Pilot Project (pdf slides) Amina ...
-
Hep B Coalition Meeting Highlights | 3-22-17
At the meeting, Korean Community Services presented their Hep B Awareness materials and gave an update on Team HBV NYC.
-
8-29-2016 LGBTQ Committee Meeting Highlights
Members of the Hep Free NYC LGBTQ Committee met to discuss activities to be implemented in 2016, including tabling at LGBTQ events and distributing the Hepatitis LGBTQ Resource Card.
-
4-28-2016 Hep C Prevention in Youth Strategic Planning Meeting Highlights
Community partners met to addresses the increase of prescription medication misuse as well as intranasal and injection drug use, that has contributed to increased rates of Hepatitis B and C nationally.
